[go: up one dir, main page]

GR920100520A - Compounds. - Google Patents

Compounds.

Info

Publication number
GR920100520A
GR920100520A GR920100520A GR920100520A GR920100520A GR 920100520 A GR920100520 A GR 920100520A GR 920100520 A GR920100520 A GR 920100520A GR 920100520 A GR920100520 A GR 920100520A GR 920100520 A GR920100520 A GR 920100520A
Authority
GR
Greece
Prior art keywords
useful
intervention
inhibition
compounds
disease conditions
Prior art date
Application number
GR920100520A
Other languages
Greek (el)
Inventor
Benjamin Christensen Siegfried
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of GR920100520A publication Critical patent/GR920100520A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

New cyclohexano-hylidene derivatives are described which interrupt production of the carcinomal necrosis factor and are useful for the treatment of disease conditions which promote or aggravate TNF production. The compounds of this invention are also useful in intervention with or inhibition of the enzymatic or catalytic action of phosphodiesterase IV and, therefore, they are useful for therapeutic treatment of disease conditions requiring their intervention or inhibition.
GR920100520A 1992-11-26 1992-11-26 Compounds. GR920100520A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR92100520 1992-11-26

Publications (1)

Publication Number Publication Date
GR920100520A true GR920100520A (en) 1994-07-29

Family

ID=10941241

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920100520A GR920100520A (en) 1992-11-26 1992-11-26 Compounds.

Country Status (1)

Country Link
GR (1) GR920100520A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2723937A1 (en) * 1976-06-03 1977-12-15 Upjohn Co 4-AMINO-4-ARYLCYCLOHEXANONE COMPOUNDS, METHODS FOR THEIR MANUFACTURING, INTERMEDIATES USED IN THEIR MANUFACTURING, AND MEDICINAL PRODUCTS
US4795757A (en) * 1984-09-04 1989-01-03 Rorer Pharmaceutical Corporation Bisarylamines
WO1991015451A1 (en) * 1990-04-05 1991-10-17 Smithkline Beecham Pharma Gmbh Novel derivatives of phenyl-cycloalkanes and -cycloalkenes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2723937A1 (en) * 1976-06-03 1977-12-15 Upjohn Co 4-AMINO-4-ARYLCYCLOHEXANONE COMPOUNDS, METHODS FOR THEIR MANUFACTURING, INTERMEDIATES USED IN THEIR MANUFACTURING, AND MEDICINAL PRODUCTS
US4795757A (en) * 1984-09-04 1989-01-03 Rorer Pharmaceutical Corporation Bisarylamines
WO1991015451A1 (en) * 1990-04-05 1991-10-17 Smithkline Beecham Pharma Gmbh Novel derivatives of phenyl-cycloalkanes and -cycloalkenes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 73, no. 21, 23 November 1970, Columbus, Ohio, US; abstract no. 109530f, '4-CYANO-4-PHENYLAMINOCYCLOHEXANES, BLOOD PRESSURE DEPRESSANTS' page 347 ; *

Similar Documents

Publication Publication Date Title
EP0633775A4 (en) Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor.
HU9600832D0 (en) Inhibitors of beta-amyloid protein production
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
ZA989667B (en) The use of MMP-13 selective inhibitors for the treatment of osteoarthritis and other MMP-mediated disorders.
NO20005884L (en) Combination therapy for the treatment of bipolar disorders
GR3001738T3 (en) Pyrrolocarbazole derivatives, processes for their preparation and their use as medicaments
WO1993019720A3 (en) Compounds
EP0649307A4 (en) Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders.
EP0651639A4 (en) Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders.
TW200640944A (en) VGF polypeptides and methods of treating VGF-related disorders
WO2001044260A8 (en) Novel purines
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
IT1290781B1 (en) ACTIVE THERAPEUTIC AGENT FOR THE TREATMENT OF NEURONAL DEGENERATIVE DISEASES.
MXPA02000680A (en) Vgf polypeptides and methods of treating vgf-related disorders.
NO20012106L (en) Means for the treatment of disorders of bone metabolism
EP0347852A3 (en) Novel neplanocin derivatives
GR920100520A (en) Compounds.
DE59708511D1 (en) USE OF 7- (1-AMINOMETHYL-2-OXA-7-AZA-BICYCLO 3.3.0] OCT-7-YL) -CHINOLONCARBOXYLIC ACID AND -NAPHTHYRIDON-CARBONIC ACID DERIVATIVES FOR THE THERAPY OF HELICOBACTER-PYLOROXIDIZED INGENATIONALIZED INGENATIONAL ADHESIVES
WO2003080800A3 (en) Prevention and treatment of disease using angiogenesis-and/or tumor antigens
DE59609977D1 (en) TRAPIDIL FOR USE IN THE THERAPY OF IMMUNO-MODULATABLE INFLUENCES
ITRM920305A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF THE SHOCK, PARTICULARLY OF THE CARDIOGEN SHOCK AND SEPTIC SHOCK.
WO1996001430A3 (en) Screening for nuc inhibitors
GR920100521A (en) Compounds.
GR920100518A (en) Compounds.
KR100344711B1 (en)